Target intelligence / Profile preview

RNA, U6 small nuclear 1299, pseudogene (RNU6-1299P)

Target
RNU6-1299P
Molecular classification
Other (Pseudogene), Non-coding RNA pseudogene, Small nuclear RNA-like pseudogene
01

Overview

RNU6-1299P, also known as RNA, U6 small nuclear 1299, pseudogene, is a human gene classified as a processed pseudogene rather than a functional protein-coding or regulatory RNA gene[1][5][11]. It is a genomic sequence derived from the U6 small nuclear RNA (snRNA) family, specifically the U6 snRNA, which is itself involved in pre-mRNA splicing as part of the spliceosome complex in its functional (non-pseudogene) forms. Pseudogenes like RNU6-1299P originate through mechanisms such as retrotransposition, notably via LINE-1 (L1) elements, resulting in copies of snRNA genes being inserted elsewhere in the genome without the regulatory elements needed for normal expression or function[2]. As a pseudogene, RNU6-1299P does not produce a functional RNA or protein, does not encode a receptor or enzyme, and there is no evidence of it being a therapeutic target or interacting directly with drugs[1][5][2]. While some pseudogenes can incidentally participate in the regulation of gene expression through mechanisms like competing endogenous RNA (ceRNA) or antisense regulation, no such function has been reported for RNU6-1299P[4][5]. It is located on chromosome 6q21 (6:107133071-107133170)[3][9].

Other names
RNU6-1299P
02

Biological functions

Other (No direct biological function; pseudogene status)
03

Disease associations

Other (No established disease association; pseudogenes sometimes implicated indirectly via RNA regulation, but no evidence specific to RNU6-1299P[5][1][7])

Beyond the preview

Go deeper on RNA, U6 small nuclear 1299, pseudogene (RNU6-1299P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1299, pseudogene (RNU6-1299P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call